aim
studi
develop
realtim
rtpcr
detect
enterovirus
ev
rhinovirus
rv
assess
perform
xtag
rvp
fast
assay
comparison
direct
fluoresc
assay
dfa
realtim
rtpcr
assay
detect
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
evrv
rtpcr
assay
develop
studi
perform
rvp
fast
assay
assess
analysi
nasopharyng
sampl
virus
dfa
panel
detect
rate
obtain
rvp
dfa
respect
analysi
set
sampl
collect
result
show
statist
signific
superior
rvp
fast
assay
p
rsv
hmpv
ev
rv
detect
rate
achiev
rvp
rtpcr
respect
individu
target
increas
detect
evrv
p
decreas
detect
influenza
viru
p
rvp
comparison
realtim
rtpcr
observ
result
present
studi
impli
need
adjust
infa
compon
rvp
fast
assay
also
cover
infa
viru
beyond
common
viral
respiratori
pathogen
numer
infecti
agent
recogn
last
decad
includ
human
metapneumoviru
hmpv
coronavirus
cov
sever
acut
respiratori
syndrom
cov
sarscov
human
bocaviru
hbov
avian
influenza
viru
nonspecif
symptom
respiratori
infect
overlap
season
variou
virus
forc
virolog
laboratori
shift
toward
molecular
assay
enabl
rapid
costeffect
detect
potenti
viral
pathogen
offer
short
turnaround
time
sensit
specif
superior
direct
fluoresc
assay
dfa
cultur
potenti
multiplex
realtim
polymeras
chain
reaction
pcr
assay
employ
fluorogen
probe
offer
remark
benefit
short
turnaround
time
nonnecess
handl
amplifi
product
howev
multiplex
realtim
pcr
assay
limit
spectral
overlap
fluoresc
label
loss
sensit
associ
multitud
oligonucleotid
factor
restrict
number
target
differenti
feasibl
approach
broaden
detect
spectrum
employ
postamplif
detect
solid
phase
li
et
al
quan
et
al
raymond
et
al
takahashi
et
al
suspens
array
format
li
et
al
mahoni
et
al
marshal
et
al
merant
et
al
nolt
et
al
pabbaraju
et
al
xtag
respiratori
viru
panel
rvp
assay
suspens
array
base
multiplex
pcr
amplif
rvp
fast
assay
sequenti
pcr
exonucleasephosphatas
reaction
targetspecif
primer
extens
step
origin
rvp
assay
replac
pcr
amplif
use
biotinlabel
primer
follow
hybrid
amplicon
fluoresc
bead
specif
antitag
sequenc
biotin
label
amplicon
enabl
attach
report
molecul
streptavidinrphycoerythrin
detect
phase
bead
identifi
signal
phycoerythrin
measur
indic
specif
amplif
product
present
rvp
fast
assay
detect
influenza
b
virus
infa
infb
respiratori
syncyti
virus
b
rsva
rsvb
parainfluenzavirus
adenoviru
adv
hmpv
cov
enterovirusrhinoviru
evrv
hbov
addit
assay
allow
subtyp
infa
virus
prepandem
season
virus
studi
perform
rvp
fast
assay
assess
comparison
dfa
realtim
rtpcr
assay
detect
rsv
hmpv
jokela
et
al
realtim
ev
rv
rtpcr
assay
first
describ
present
studi
sampl
sent
huslab
helsinki
univers
central
hospit
routin
viru
diagnost
decemb
april
nasopharyng
aspir
swab
bronchoalveolar
lavag
sampl
pediatr
adult
patient
respiratori
symptom
avail
present
studi
addit
respiratori
sampl
posit
infa
realtim
rtpcr
et
al
ward
et
al
sampl
posit
either
infb
dfa
analyz
evalu
rvp
fast
assay
sampl
collect
furthermor
valid
sampl
natrol
respiratori
valid
panel
global
panel
zeptometrix
corp
buffalo
ny
usa
contain
infa
infa
infb
rsva
rsvb
ev
rv
cov
sarscov
analyz
rvp
fast
assay
addit
qualiti
assess
sampl
ev
parechoviru
rna
extern
qualiti
assess
eqa
program
qualiti
control
molecular
diagnost
qcmd
glasgow
scotland
uk
contain
echovirus
ec
coxsacki
viru
coxsacki
b
viru
polioviru
type
well
sampl
contain
cov
rv
cov
rna
eqa
program
organ
analyz
use
realtim
rtpcr
assay
ev
rv
develop
studi
cell
clinic
sampl
concentr
centrifug
appli
multiwel
slide
dri
fix
aceton
slide
test
adv
infa
infb
rsv
use
light
diagnost
tm
respiratori
dfa
viral
screen
identif
kit
millipor
billerica
usa
accord
manufactur
instruct
sampl
suffici
number
cell
analysi
includ
studi
total
nucleic
acid
sampl
store
c
isol
magna
pure
robot
roch
diagnost
basel
switzerland
extract
immedi
subject
rvp
fast
assay
luminex
molecular
diagnost
inc
toronto
canada
intern
posit
control
escherichia
coli
phage
provid
manufactur
ad
sampl
extract
aliquot
extract
store
c
later
test
ev
rv
realtim
rtpcr
describ
rvp
fast
assay
perform
accord
manufactur
instruct
posit
run
control
bacteriophag
lambda
dna
use
run
monitor
assay
perform
result
median
fluoresc
intens
mfi
analyz
luminex
system
tda
rvp
fast
version
luminex
realtim
rtpcr
detect
rsv
hmpv
perform
simultan
rvp
fast
assay
describ
previous
jokela
et
al
detect
ev
rv
three
primer
two
probe
highli
conserv
untransl
region
viral
genom
design
gacatggtgygaagagtctattgag
aggtgtgaagagccccgtgt
picornar
gaaacacggacacccaaagtagt
evprob
famcggcccctgaatgcggctaatcc
rvprobe
hexccggcccctgaatgyggctaacct
furthermor
primer
gacatggtgygaagagtctattgagct
nm
aaggtgtgaagagccccgtgt
nm
use
reanalysi
clinic
sampl
discord
result
reaction
condit
evrv
rtpcr
describ
previous
jokela
et
al
except
duplex
rtpcr
concentr
mm
manganes
acet
u
amplitaq
gold
polymeras
roch
use
modifi
primer
concentr
use
nm
nm
picornar
nm
optim
concentr
ev
rv
probe
nm
nm
respect
optim
assay
perform
use
rna
transcript
clone
jokela
et
al
analysi
clinic
sampl
perform
three
reaction
one
ev
pcr
one
rv
pcr
one
duplex
pcr
precis
studi
evrv
rtpcr
perform
use
dilut
seri
rna
transcript
correspond
genom
equival
per
reaction
intraassay
variabl
evalu
run
five
parallel
reaction
dilut
seri
one
plate
interassay
variabl
test
one
dilut
seri
four
consecut
day
concord
result
obtain
clinic
sampl
rvp
fast
assay
dfa
well
rvp
fast
rtpcr
examin
mcnemar
test
use
spsspasw
statist
program
packag
version
ibmspss
armonk
ny
usa
statist
signific
set
p
sensit
rna
transcript
respect
achiev
separ
rtpcr
reaction
rna
transcript
correspond
copi
per
ml
sampl
duplex
assay
precis
studi
mean
intraassay
coeffici
variat
cv
cycl
threshold
ct
valu
mean
interassay
cv
respect
analysi
ev
parechoviru
qualiti
assess
sampl
sampl
posit
ev
two
sampl
remain
neg
consist
result
report
organ
rtpcr
sampl
rv
cov
program
detect
rv
type
except
dilut
provid
signal
detect
neg
control
sampl
contain
cov
one
qualiti
assess
sampl
contain
gave
posit
signal
ev
probe
furthermor
sampl
contain
posit
probe
duplex
rtpcr
therefor
rtpcr
assay
consid
incap
distinguish
two
picornaviru
genera
similar
rvp
fast
assay
posit
result
consid
indic
ev
rv
virus
present
global
panel
detect
analysi
except
sarscov
detect
rvp
fast
assay
clinic
sampl
fail
give
valid
result
intern
control
initi
test
valid
result
sampl
obtain
repeat
postamplif
step
howev
extract
nucleic
acid
anew
repeat
analysi
gave
valid
result
nine
sampl
remain
three
sampl
valid
result
rvp
analysi
exclud
analysi
therefor
result
sampl
set
describ
remain
sampl
failur
detect
posit
run
control
virus
cover
dfa
panel
signific
differ
overal
detect
rate
rvp
fast
assay
dfa
detect
p
sinc
sampl
sampl
sampl
set
posit
least
one
viru
rvp
fast
assay
dfa
respect
consid
posit
result
viral
target
includ
detect
rate
sampl
rvp
fast
observ
due
broader
detect
spectrum
provid
assay
analysi
sampl
set
sampl
posit
rsv
hmpv
ev
rv
rvp
fast
assay
sampl
rtpcr
assay
rtpcrposit
sampl
posit
singl
duplex
reaction
coinfect
identifi
specimen
rvp
fast
assay
detect
dual
infect
two
tripl
infect
rtpcr
detect
addit
five
coinfect
result
rvp
fast
assay
individu
target
comparison
dfa
pcr
provid
tabl
furthermor
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
rvp
fast
assay
use
dfa
gold
standard
provid
except
evrv
hmpv
pcr
use
gold
standard
rsv
infa
calcul
done
separ
use
gold
standard
perform
rvp
fast
assay
detect
ev
rv
hmpv
sampl
set
assess
comparison
rtpcr
assay
sampl
posit
evrv
rvp
fast
assay
rtpcr
six
sampl
pcrneg
initi
analysi
evposit
reanalysi
use
primer
addit
rtpcrneg
sampl
discord
result
obtain
seven
rvpneg
sampl
tabl
four
rvpneg
sampl
turn
evrvposit
rtpcr
mean
ct
addit
rtpcr
detect
evrv
two
sampl
posit
rsv
one
sampl
posit
adv
rvp
fast
assay
mean
ct
evrv
detect
rate
obtain
rvp
fast
assay
rtpcr
respect
differ
detect
rate
evrv
rvp
fast
assay
rtpcr
statist
signific
p
sampl
sampl
set
collect
posit
hmpv
posit
rvp
rtpcr
mean
ct
one
sampl
weakli
posit
hmpv
rtpcr
ct
hmpvneg
posit
adv
hbov
rvp
fast
assay
detect
rate
hmpv
rvp
rtpcr
respect
rvp
fast
assay
detect
infa
four
sampl
sampl
set
unabl
type
viru
sampl
one
rvpposit
sampl
remain
neg
dfa
three
four
posit
sampl
avail
analysi
tabl
perform
rvp
fast
assay
detect
nine
sampl
posit
adv
five
remain
neg
dfa
addit
one
rvpneg
sampl
appear
posit
dfa
sampl
posit
eleven
posit
rvp
fast
assay
seven
also
posit
dfa
one
sampl
posit
dfa
detect
sampl
set
due
low
preval
piv
sampl
set
addit
sampl
posit
dfa
analyz
rvp
fast
assay
posit
result
obtain
sampl
virus
detect
measur
avail
helsinki
univers
central
hospit
laboratori
rvp
fast
assay
detect
cov
sampl
detect
rate
eight
sampl
detect
rate
three
sampl
detect
rate
sampl
set
cov
detect
sampl
posit
hbov
multiplex
pcr
detect
amplif
product
suspens
microarray
recent
diagnost
advanc
among
effort
identifi
respiratori
virus
rapid
costeffect
manner
studi
perform
suspens
microarraybas
rvp
fast
assay
analysi
nasopharyng
sampl
assess
result
rvp
fast
assay
compar
dfa
well
realtim
rsv
hmpv
rtpcr
assay
jokela
et
al
realtim
evrv
rtpcr
assay
first
describ
studi
sensit
rvp
fast
assay
cov
hbov
could
assess
studi
design
previou
measur
detect
virus
test
algorithm
helsinki
univers
central
hospit
laboratori
exist
rvp
fast
assay
rapid
simpl
perform
requir
rel
littl
handson
time
togeth
larg
amount
data
produc
one
analysi
desir
featur
routin
diagnost
notabl
sampl
reanalyz
due
invalid
control
call
initi
rvp
analysi
togeth
result
rna
lambda
phage
dna
show
failur
assay
due
faulti
nucleic
acid
extract
rt
reaction
inde
repeat
test
includ
rtpcr
step
produc
valid
result
case
reanalysi
total
sampl
produc
valid
result
rvp
analysi
analysi
sampl
set
result
remark
increas
overal
detect
rate
respiratori
virus
rvp
fast
assay
dfa
virus
current
cover
dfa
panel
consid
entir
detect
spectrum
rvp
fast
assay
detect
rate
achiev
similar
find
also
report
previou
studi
use
rvp
fast
assay
gadsbi
et
al
origin
rvp
assay
gharabaghi
et
al
mahoni
et
al
preval
coinfect
detect
present
studi
rvp
fast
assay
similar
preval
shown
other
gadsbi
et
al
mahoni
et
al
pabbaraju
et
al
high
ct
valu
fals
rvpneg
sampl
report
rvp
fast
assay
gadsbi
et
al
origin
rvp
assay
mahoni
et
al
similarli
observ
discord
result
rvpneg
sampl
associ
rel
low
viral
load
mean
ct
rtpcr
except
target
miss
rvp
infa
rsv
hmpv
ev
rv
increas
overal
detect
rate
rvp
fast
assay
rtpcr
observ
detect
evrv
statist
signific
differ
shown
detect
rate
rvp
fast
assay
increas
rtpcr
impli
inhous
rtpcr
assay
may
abl
detect
ev
rv
although
addit
freezethaw
cycl
may
also
influenc
result
evrv
rtpcr
also
unabl
distinguish
two
picornaviru
genera
nonetheless
posit
result
indic
repres
either
genu
infa
find
unsubtyp
rvp
fast
assay
highli
indic
pandem
infa
ginocchio
st
georg
vinikoor
et
al
inde
three
infaposit
sampl
test
realtim
rtpcr
posit
novel
infa
et
al
sinc
four
sampl
date
back
decemb
like
contain
infa
howev
perform
rvp
fast
assay
detect
infa
assess
signific
decreas
detect
rate
rvp
fast
assay
compar
realtim
rtpcr
assay
util
observ
inde
result
studi
suggest
adjust
infa
compon
assay
also
cover
novel
infa
viru
although
low
sensit
rvp
fast
assay
detect
infb
describ
previous
gharabaghi
et
al
discord
find
present
studi
gener
overal
perform
assay
result
obtain
rvp
fast
assay
show
reliabl
detect
piv
low
preval
sampl
studi
limit
interpret
result
sinc
low
sensit
rvp
fast
assay
describ
previous
gharabaghi
et
al
greater
number
posit
sampl
would
essenti
assess
assay
perform
detect
target
due
low
sensit
dfa
contemporari
basi
respiratori
viru
diagnosi
helsinki
univers
central
hospit
laboratori
neg
test
result
interpret
rule
viral
infect
thu
higher
sensit
desir
implement
rvp
fast
assay
daili
diagnosi
respiratori
infect
would
result
neg
find
clinic
relev
sinc
neg
result
reliabl
perform
rvp
analysi
may
consid
absenc
spectrum
pathogen
sampl
evalu
rvp
fast
assay
demonstr
adopt
pcrbase
multiplex
assay
result
remark
increas
overal
viral
detect
rate
respiratori
virus
compar
convent
method
rel
high
preval
evrv
cov
hmpv
hbov
studi
popul
also
emphas
need
broader
detect
spectrum
respiratori
viru
diagnost
achiev
dfa
moreov
cost
analysi
studi
mahoni
et
al
suggest
substanti
save
may
achiev
test
xtag
rvp
test
alon
save
result
shorten
length
hospit
stay
howev
sinc
batch
sampl
rvp
analysi
retard
test
result
dfa
still
method
choic
pcrbase
test
slow
support
clinic
decis
broadspectrum
rvp
analysi
result
sampl
two
viral
pathogen
identifi
although
clinic
relev
find
current
clear
suggest
coinfect
one
viru
may
result
greater
diseas
sever
longer
hospit
stay
cilla
et
al
esper
et
al
et
al
multiplex
test
becom
common
understand
epidemiolog
respiratori
virus
may
improv
clinic
import
mix
infect
systemat
studi
